VLADIMIR MELYAKOV
Allopathic & Osteopathic Physicians|Hospitalist FARMINGTON, MO NPI 1912970880
Browse related groups: Allopathic & Osteopathic Physicians|Hospitalist MO Novo Nordisk AS All categories
General Payments — all program years on this page
$658.65
- Category: General Payments
- Program years: PY2018–2024
- Record count: 33
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $190.26 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.26 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $61.95 | 3 |
| Vapotherm Inc | $34.99 | 2 |
| UCB, Inc. | $30.25 | 1 |
| Merck Sharp & Dohme Corporation | $22.57 | 1 |
| Janssen Pharmaceuticals, Inc | $21.16 | 1 |
| Gilead Sciences, Inc. | $19.34 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078057602 | Janssen Pharmaceuticals, Inc | $21.16 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096622178 | Novo Nordisk Inc | $19.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096958550 | Novo Nordisk Inc | $24.99 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096963862 | Novo Nordisk Inc | $17.46 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1129424393 | Vapotherm Inc | $18.53 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1129424395 | Vapotherm Inc | $16.46 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133838228 | Gilead Sciences, Inc. | $19.34 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141721288 | Merck Sharp & Dohme LLC | $22.57 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143113751 | UCB, Inc. | $30.25 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.